Colon Disease
Conditions
Brief summary
A randomized control trial comparing a standard bowel preparation for colonoscopy with an individualized bowel preparation strategy based on patient characteristics
Interventions
standard PEG-based bowel preparation for colonoscopy (either split dose 4L polyethylene glycol or split 2L PEG + ascorbic acid)
DRUGIndividualized Preparation
individualized bowel preparation for colonoscopy (either split dose 4L PEG or split 2L PEG + ascorbic acid) based o patient characteristics (history of failed bowel preparation; use of laxative drugs, increased BMI, age\>65, neurologic comorbidities)
Sponsors
Clinical Hospital Colentina
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)
Masking description
single-blind
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* elective out-patient diagnostic or therapeutic colonoscopy
Exclusion criteria
* pregnant women; refusal to participate; significant comorbidities (ASA score 3 or above); suspicion of bowel perforation;
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| bowel preparation quality | 1-2 hours after completing bowel preparation | Boston bowel preparation score (BBPS) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| patient comfort during bowel preparation | 1-2 hours after completing bowel preparation | 0-10 patient comfort score using a standard visual-analogue scale |
Countries
Romania
Contacts
Primary ContactTheodor Voiosu, MD, PhD
Outcome results
None listed